Clinical Trial Update: A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating preladenant in participants with chronic hepatic impairment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment
• Liver Disease

Drugs mentioned

• preladenant (preladenant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2016-04-06